Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie W Chinn

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 18, 2007
The effects of ABCB1 3'-untranslated region variants on mRNA stabilityJason M Gow, Leslie W Chinn, Deanna L Kroetz
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Substrate-dependent effects of human ABCB1 coding polymorphismsJason M Gow, Laura M Hodges, Leslie W Chinn, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2007
Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoproteinLeslie W Chinn, Jason M Gow, Man Ming Tse, et al.
Clinical Pharmacology and Therapeutics|August 4, 2019
Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDINicholas S Jones, Kenta Yoshida, Laurent Salphati, et al.
Plos One|December 20, 2008
Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adultsJayne Byakika-Tusiime, Leslie W Chinn, Jessica H Oyugi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and MethotrexateNicholas Steven Jones, Helen Winter, Tamiko R Katsumoto, et al.
Pharmacogenetics and Genomics|August 29, 2013
Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?Janine E Micheli, Leslie W Chinn, Sarah B Shugarts, et al.
Pharmacogenetics and Genomics|March 11, 2010
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Laura M Hodges, Svetlana M Markova, Leslie W Chinn, et al.
International Journal of Toxicology|November 11, 2024
Enhanced Prenatal and Postnatal Development Study in Marmoset Monkeys Following Administration of FelzartamabDoris Mangelberger-Eberl, Mary Ellen Cosenza, Stefan Härtle, et al.
Protein Science : a Publication of the Protein Society|August 28, 2010
Functional hot spots in human ATP-binding cassette transporter nucleotide binding domainsLibusha Kelly, Hisayo Fukushima, Rachel Karchin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 18, 2007
The effects of ABCB1 3'-untranslated region variants on mRNA stabilityJason M Gow, Leslie W Chinn, Deanna L Kroetz
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Substrate-dependent effects of human ABCB1 coding polymorphismsJason M Gow, Laura M Hodges, Leslie W Chinn, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2007
Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoproteinLeslie W Chinn, Jason M Gow, Man Ming Tse, et al.
Clinical Pharmacology and Therapeutics|August 4, 2019
Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDINicholas S Jones, Kenta Yoshida, Laurent Salphati, et al.
Plos One|December 20, 2008
Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adultsJayne Byakika-Tusiime, Leslie W Chinn, Jessica H Oyugi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and MethotrexateNicholas Steven Jones, Helen Winter, Tamiko R Katsumoto, et al.
Pharmacogenetics and Genomics|August 29, 2013
Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?Janine E Micheli, Leslie W Chinn, Sarah B Shugarts, et al.
Pharmacogenetics and Genomics|March 11, 2010
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Laura M Hodges, Svetlana M Markova, Leslie W Chinn, et al.
International Journal of Toxicology|November 11, 2024
Enhanced Prenatal and Postnatal Development Study in Marmoset Monkeys Following Administration of FelzartamabDoris Mangelberger-Eberl, Mary Ellen Cosenza, Stefan Härtle, et al.
Protein Science : a Publication of the Protein Society|August 28, 2010
Functional hot spots in human ATP-binding cassette transporter nucleotide binding domainsLibusha Kelly, Hisayo Fukushima, Rachel Karchin, et al.
Pageof 2